7월 26, 2018 Certara Experts Highlight Quantitative Systems Pharmacology’s Role in First-in-human Clinical Trials
6월 14, 2018 Certara Supports the Not-for-profit Biotechnology Company Medicines Development for Global Health (MDGH) on the FDA New Drug Approval of Moxidectin for the Treatment of River Blindness (Onchocerciasis), a Neglected Tropical Disease
6월 5, 2018 Certara Launches Version 8.1 of its Industry-leading Phoenix PK/PD Modeling and Simulation Software; Introduces Professional Certification Program
5월 29, 2018 Certara Scientists to Present Model-informed Drug Development, Systems Pharmacology and MBMA Advances at PAGE 2018
4월 12, 2018 Certara Acquires Analytica Laser, a Leader in Market Access, Health Economics and Outcomes Research (HEOR), and Real-world Evidence Solutions
3월 13, 2018 Certara Launches Industry-first Quantitative Systems Pharmacology (QSP) Consortium on Immuno-oncology with Leading Pharma Company Members
3월 12, 2018 Certara and Faculty from UNC Eshelman School of Pharmacy to Launch New Pharmacometrics Skills Competition at ASCPT 2018 Annual Meeting
2월 14, 2018 Certara Launches Version 10 of D360, Its Industry-leading Drug Discovery Informatics Platform